Click here to access the Swedish Press Library 🇸🇪 Press contact:Cecilia Edströmcecilia.edstrom@a3p.com+46 72 226 2328 Caj Westlund 31/08/2022 Caj Westlund 31/08/2022 A3P Biomedical forms Scientific Advisory Board Read More Caj Westlund 23/08/2022 Caj Westlund 23/08/2022 Stockholm3 in NICE Medtech Innovation Briefing for the UK Read More Caj Westlund 09/08/2022 Caj Westlund 09/08/2022 Stockholm3 in the Swedish national guidelines for prostate cancer Read More Caj Westlund 05/07/2022 Caj Westlund 05/07/2022 Stockholm3 study is named the best scientific publication by the European Association of Urology Read More Caj Westlund 16/06/2022 Caj Westlund 16/06/2022 A3P Biomedical initiates partnership with Unilabs for Stockholm3 Read More Caj Westlund 13/06/2022 Caj Westlund 13/06/2022 Region Värmland introduces Stockholm3 in its organized program for prostate cancer screening Read More Caj Westlund 09/06/2022 Caj Westlund 09/06/2022 New Finnish study validates Stockholm3 and shows health economic benefits Read More Caj Westlund 18/05/2022 Caj Westlund 18/05/2022 A3P Biomedical appoints Anders Martin-Löf as new CFO Read More Caj Westlund 05/05/2022 Caj Westlund 05/05/2022 A3P Biomedical has successfully completed a Private Placement of SEK 400 million Read More Caj Westlund 28/02/2022 Caj Westlund 28/02/2022 Study published in European Urology Open Science confirms that Stockholm3 provides increased precision in prostate cancer diagnosis Read More Caj Westlund 17/02/2022 Caj Westlund 17/02/2022 Stockholm3 in proposal for new national guidelines in Sweden Read More Caj Westlund 17/02/2022 Caj Westlund 17/02/2022 Stockholm3 included in the proposal for new national guidelines in Sweden Read More Caj Westlund 28/01/2022 Caj Westlund 28/01/2022 New analysis in European Urology finds Stockholm3 cost effective for population-based screening Read More Caj Westlund 11/01/2022 Caj Westlund 11/01/2022 Stockholm3 developer Henrik Grönberg named Cancer Researcher of the Year Read More Caj Westlund 13/08/2021 Caj Westlund 13/08/2021 Fast track publication of the STHLM3 MRI trial in The Lancet Oncology Read More Caj Westlund 14/07/2021 Caj Westlund 14/07/2021 Stockholm3 abstract wins 1st prize at European Association of Urology Read More Caj Westlund 18/06/2021 Caj Westlund 18/06/2021 A3P Biomedical recruits new CEO to lead commercial expansion Read More Caj Westlund 19/03/2021 Caj Westlund 19/03/2021 Prostate cancer screening with Stockholm3 reduces unnecessary biopsies and is cost-effective Read More Caj Westlund 10/01/2021 Caj Westlund 10/01/2021 A3P Biomedical strengthens the management team for international expansion Read More Caj Westlund 21/10/2020 Caj Westlund 21/10/2020 A3P Biomedical raises SEK 110 million in growth capital Read More Newer Posts Older Posts
Caj Westlund 31/08/2022 Caj Westlund 31/08/2022 A3P Biomedical forms Scientific Advisory Board Read More
Caj Westlund 23/08/2022 Caj Westlund 23/08/2022 Stockholm3 in NICE Medtech Innovation Briefing for the UK Read More
Caj Westlund 09/08/2022 Caj Westlund 09/08/2022 Stockholm3 in the Swedish national guidelines for prostate cancer Read More
Caj Westlund 05/07/2022 Caj Westlund 05/07/2022 Stockholm3 study is named the best scientific publication by the European Association of Urology Read More
Caj Westlund 16/06/2022 Caj Westlund 16/06/2022 A3P Biomedical initiates partnership with Unilabs for Stockholm3 Read More
Caj Westlund 13/06/2022 Caj Westlund 13/06/2022 Region Värmland introduces Stockholm3 in its organized program for prostate cancer screening Read More
Caj Westlund 09/06/2022 Caj Westlund 09/06/2022 New Finnish study validates Stockholm3 and shows health economic benefits Read More
Caj Westlund 18/05/2022 Caj Westlund 18/05/2022 A3P Biomedical appoints Anders Martin-Löf as new CFO Read More
Caj Westlund 05/05/2022 Caj Westlund 05/05/2022 A3P Biomedical has successfully completed a Private Placement of SEK 400 million Read More
Caj Westlund 28/02/2022 Caj Westlund 28/02/2022 Study published in European Urology Open Science confirms that Stockholm3 provides increased precision in prostate cancer diagnosis Read More
Caj Westlund 17/02/2022 Caj Westlund 17/02/2022 Stockholm3 in proposal for new national guidelines in Sweden Read More
Caj Westlund 17/02/2022 Caj Westlund 17/02/2022 Stockholm3 included in the proposal for new national guidelines in Sweden Read More
Caj Westlund 28/01/2022 Caj Westlund 28/01/2022 New analysis in European Urology finds Stockholm3 cost effective for population-based screening Read More
Caj Westlund 11/01/2022 Caj Westlund 11/01/2022 Stockholm3 developer Henrik Grönberg named Cancer Researcher of the Year Read More
Caj Westlund 13/08/2021 Caj Westlund 13/08/2021 Fast track publication of the STHLM3 MRI trial in The Lancet Oncology Read More
Caj Westlund 14/07/2021 Caj Westlund 14/07/2021 Stockholm3 abstract wins 1st prize at European Association of Urology Read More
Caj Westlund 18/06/2021 Caj Westlund 18/06/2021 A3P Biomedical recruits new CEO to lead commercial expansion Read More
Caj Westlund 19/03/2021 Caj Westlund 19/03/2021 Prostate cancer screening with Stockholm3 reduces unnecessary biopsies and is cost-effective Read More
Caj Westlund 10/01/2021 Caj Westlund 10/01/2021 A3P Biomedical strengthens the management team for international expansion Read More
Caj Westlund 21/10/2020 Caj Westlund 21/10/2020 A3P Biomedical raises SEK 110 million in growth capital Read More
